| # | Drug | Count |
|---|---|---|
| 0 | AMOXICILLIN | 104 |
| 1 | DASATINIB | 81 |
| 2 | METRONIDAZOLE | 63 |
| 3 | CLARITHROMYCIN | 58 |
| 4 | PREDNISONE | 55 |
| 5 | OSELTAMIVIR PHOSPHATE | 54 |
| 6 | METHOTREXATE SODIUM | 53 |
| 7 | IPILIMUMAB | 48 |
| 8 | METRONIDAZOLE TOPICAL | 48 |
| 9 | OMEPRAZOLE MAGNESIUM | 48 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMPICILLIN AND SULBACTAM | 19 | 0.0216 |
| 1 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 29 | 0.0112 |
| 2 | OLSALAZINE SODIUM | 2 | 0.0102 |
| 3 | DASATINIB | 81 | 0.0087 |
| 4 | INDIUM IN -111 PENTETREOTIDE | 1 | 0.0078 |
| 5 | MEGNESIUM OXIDE | 3 | 0.0072 |
| 6 | TRIENTINE TETRAHYDROCHLORIDE | 2 | 0.0065 |
| 7 | TRIENTINE HYDROCHLORIDE | 1 | 0.0054 |
| 8 | OMEPRAZOLE 20 MG | 1 | 0.0049 |
| 9 | ISRADIPINE | 2 | 0.0036 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 179 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 102 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 93 |
| 3 | Proton Pump Inhibitor [EPC] | 89 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 74 |
| 5 | Nitroimidazole Antimicrobial [EPC] | 64 |
| 6 | Platinum-based Drug [EPC] | 59 |
| 7 | Macrolide Antimicrobial [EPC] | 58 |
| 8 | Factor Xa Inhibitor [EPC] | 57 |
| 9 | Kinase Inhibitor [EPC] | 52 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | beta Lactamase Inhibitor [EPC] | 5 | 0.0011 |
| 2 | Macrolide Antimicrobial [EPC] | 58 | 0.0011 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 49 | 0.0010 |
| 4 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 5 | Nitroimidazole Antimicrobial [EPC] | 64 | 0.0010 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 7 | 0.0008 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 74 | 0.0008 |
| 8 | Nuclear Export Inhibitor [EPC] | 6 | 0.0007 |
| 9 | Interleukin-17A Antagonist [EPC] | 21 | 0.0006 |